advanced search
Matthew Huddleston
Executive Vice-President and Chief Technology Officer
Enable Injections

Is this your profile?

About

Matthew J Huddleston serves as Executive Vice-President and Chief Technology Officer for Enable Injections. He is an experienced medical device professional with over 25 years’ experience in startup environments with emphasis in project management, design, development, manufacturing, regulatory and intellectual property. He is a professional engineer and a licensed patent agent. Mr Huddleston holds a Bachelor of Science in Mechanical Engineering from Purdue University (West Lafayette, IN, US) and a Master of Science in Biomedical Engineering from The Ohio State University (Columbus, OH, US).

Contributions

WEARABLES
DRUG DELIVERY: WHAT DO PATIENTS AND PROVIDERS WANT?
Matthew Huddleston and Jennifer Estep discuss current drug delivery options and the value of convenient care.

More contributions

WEARABLES
KEY CHALLENGES IN SUCCESSFUL WEARABLE DRUG DELIVERY & PATIENT SELF-ADMINISTRATION
Matthew Huddleston, Andrew Eibling and Jennifer King look at the key challenges involved in successful wearable drug delivery technology and patient self-administration.
#97 May 2019 - enable_featured
EXPERT VIEW
PATIENT TOLERABILITY WITH HIGH-VISCOSITY, LARGE-VOLUME SUBCUTANEOUS INFUSIONS
Jennifer King and Matthew J Huddleston discuss the advantages of subcutaneous drug delivery and how these have yet to be fully harnessed in currently marketed therapeutics.
CONNECTIVITY
BEYOND CONNECTIVITY: ENABLE & FLEX ANNOUNCE THE ENABLE SMART DEVICE
Matthew J Huddleston and Angela Wright talk about integrating Bluetooth connectivity into Enable’s latest Smart On-Body Delivery Device, describing how the Flex/Enable partnership has also been expanded to encompass Flex’s Digital Health Platform.
Top